NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
Buyer: NHS England
- End date in notice
- Date not published
- Value shown in notice
- £1Value from the linked contract
About this figure
- This figure comes from the linked contract record. Overall totals continue to use the separately published award value.
View record references
- Source
- Find a Tender
- Award or lot reference
ocds-h6vhtk-04e273 / 043951-2025-10